Irwin Naturals Reports Q2 2023 Financial Results

LOS ANGELES, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) reported its financial results for its second quarter of fiscal 2023, the period ended June 30, 2023, on www.sedar.com. Financial Highlights for Q2 2023 Q2 revenue was $22.1 million, up 1.5% from $21.8 million in Q2 2022.Income from operations decreased $2.4 million from $0.5 million in Q2 2022 to a loss of $1.9 million in Q2 2023. The decrease is primarily attributed

Related Keywords

Michigan ,United States ,Oregon ,Mississippi ,California ,Colorado ,Oklahoma ,New Mexico ,Canada ,America ,Klee Irwin ,Keta Media ,Irwin Naturals Inc ,Serenity Health ,Us Drug Enforcement Agency ,Company Investor Relations Department ,Drug Administration ,Irwin Naturals ,Date June ,Ketamine Media ,North America ,Investor Relations ,Controlled Substances Act ,Narcotic Control Regulations ,Controlled Substances Acts ,Enforcement Agency ,Market Regulator ,Months Ended June ,Interim Statements ,Financial Position ,Voting Shares ,Comprehensive Income ,Six Months Ended June ,Cash Flows ,The Company ,Brand Licensing ,Advertising Company ,